SAP invests in Avelios Medical
News Artikel
SAP, one of our long-standing limited partners, makes a strategic investment in our portfolio company Avelios Medical, a company that is reshaping hospital IT and clinical workflows. Together, Avelios and SAP offer an open, AI-native and sovereign platform, developed in Europe and designed for enterprise-scale hospital rollouts.
SAP’s commitment reflects conviction in a company that HTGF has backed at the earliest stage. At HTGF, we sit at the intersection of bold founders and industry-defining LPs. When the two sides connect that’s the HTGF flywheel working.
What makes Avelios particularly compelling is its timing. The IS-H transformation is reshaping the clinical IT market, and hospitals facing fundamental IT realignments need orientation. Avelios is exactly that. The company offers a platform that integrates clinical workflows, patient data, and administrative processes – built on a structured, semantically consistent data model that enables interoperability and clinical intelligence at enterprise scale.

Ich bin Ansprechpartner
für alle Pressefragen:
Tobias Jacob
Weitere News
zum Artikel
T-CURX acquires Pantherna Therapeutics to accelerate clinical translation of its non-viral in vivo CAR-T strategies
zum Artikel
FDA erteilt beschleunigte Zulassung für Hepcludex – ursprünglich entwickelt vom HTGF-Portfoliounternehmen MYR GmbH
zum Artikel
Cool. Quiet. Clean. Fraunhofer-Ausgründung Qurie sichert sich 2,2 Millionen Euro für die Kühl-Technologie der Zukunft
zum Artikel
eyeo B.V. sammelt 40 Millionen Euro ein, um eine grundlegende Design-Limitation zu überwinden, die Kameras 70 % des Lichts kostet
zum Artikel
Lebensmittelsicherheit in Stunden statt Tagen: NanoStruct sichert sich 2,6 Mio. € Seed-Finanzierung
zum Artikel